BACKGROUND In this study, we identified the lipidomic predictors of early type 2 diabetic kidney disease (DKD) progression, which are currently undefined.METHODS This longitudinal study included 92 American Indians with type 2 diabetes. Serum lipids (406 from 18 classes) were quantified using mass spectrometry from baseline samples when iothalamate-based glomerular filtration rate (GFR) was at least 90 mL/min. Affymetrix GeneChip Array was used to measure renal transcript expression. DKD progression was defined as at least 40% decline in GFR during follow-up.RESULTS Participants had a mean age of 45 ± 9 years and median urine albumin/creatinine ratio of 43 (interquartile range 11–144). The 32 progressors had significantly higher relative abundance of polyunsaturated triacylglycerols (TAGs) and a lower abundance of C16–C20 acylcarnitines (ACs) (P < 0.001). In a Cox regression model, the main effect terms of unsaturated free fatty acids and phosphatidylethanolamines and the interaction terms of C16–C20 ACs and short-low-double-bond TAGs by categories of albuminuria independently predicted DKD progression. Renal expression of acetyl-CoA carboxylase–encoding gene (ACACA) correlated with serum diacylglycerols in the glomerular compartment (r = 0.36, and P = 0.006) and with low-double-bond TAGs in the tubulointerstitial compartment (r = 0.52, and P < 0.001).CONCLUSION Collectively, the findings reveal a previously unrecognized link between lipid markers of impaired mitochondrial β-oxidation and enhanced lipogenesis and DKD progression in individuals with preserved GFR. Renal acetyl-CoA carboxylase activation accompanies these lipidomic changes and suggests that it may be the underlying mechanism linking lipid abnormalities to DKD progression.TRIAL REGISTRATION ClinicalTrials.gov, NCT00340678.FUNDING NIH R24DK082841, K08DK106523, R03DK121941, P30DK089503, P30DK081943, and P30DK020572.
Farsad Afshinnia, Viji Nair, Jiahe Lin, Thekkelnaycke M. Rajendiran, Tanu Soni, Jaeman Byun, Kumar Sharma, Patrice E. Fort, Thomas W. Gardner, Helen C. Looker, Robert G. Nelson, Frank C. Brosius, Eva L. Feldman, George Michailidis, Matthias Kretzler, Subramaniam Pennathur
Title and authors | Publication | Year |
---|---|---|
Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease
Guo X, Zhang Z, Li C, Li X, Cao Y, Wang Y, Li J, Wang Y, Wang K, Liu Y, Xie C, Zhong Y |
Metabolism Open | 2025 |
Metabolomics for the Identification of Biomarkers in Kidney Diseases
Pandey S |
Nanotheranostics | 2025 |
Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications.
Yan L, Wang X, Xiang Y, Ru S, Fang C, Wu X |
Metabolomics : Official journal of the Metabolomic Society | 2025 |
Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies
Yu W, Haoyu Y, Ling Z, Xing H, Pengfei X, Anzhu W, Lili Z, Linhua Z |
Frontiers in Immunology | 2025 |
Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study
Su J, Hu J, Liu H, Guo Y, Shi Y, Zheng Y, Dong Z, Liu J, Xu Z, Yu X, Mei J, Peng J, Wang L, Liu Q |
Diabetology & Metabolic Syndrome | 2025 |
P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism
Lu X, Wu J, Agborbesong E, Li X |
Cell Death Discovery | 2025 |
Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.
Hao Y, She X, Huang G, Chu X, Zhao S, Lv Z, Tao J, Zhang Y |
BMC ophthalmology | 2025 |
DHA–Triacylglycerol Accumulation in Tacrolimus-Induced Nephrotoxicity Identified by Lipidomic Profiling
Nishida S, Ishima T, Iwami D, Nagai R, Aizawa K |
International Journal of Molecular Sciences | 2025 |
Diabetic retinal disease.
Sivaprasad S, Wong TY, Gardner TW, Sun JK, Bressler NM |
Nature reviews. Disease primers | 2025 |
Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease
Wang MY, Zhang Z, Zhao S, Onodera T, Sun X, Zhu Q, Li C, Li N, Chen S, Paredes M, Gautron L, Charron MJ, Marciano DK, Gordillo R, Drucker DJ, Scherer PE |
Cell Metabolism | 2024 |
Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF |
The Cochrane Database of Systematic Reviews | 2024 |
Molecular mechanism of renal lipid accumulation in diabetic kidney disease
Fang Z, Liu R, Xie J, He JC |
Journal of Cellular and Molecular Medicine | 2024 |
The key role of altered tubule cell lipid metabolism in kidney disease development
Lee LE, Doke T, Mukhi D, Susztak K |
Kidney International | 2024 |
Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome
Cortés-Camacho F, Zambrano-Vásquez OR, Aréchaga-Ocampo E, Castañeda-Sánchez JI, Gonzaga-Sánchez JG, Sánchez-Gloria JL, Sánchez-Lozada LG, Osorio-Alonso H |
Antioxidants | 2024 |
Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission
Afshinnia F, Rajendiran TM, Byun J, Arnipalli MS, Rehaume LM, Cross JL, Huizinga RB, Pennathur S |
Kidney International Reports | 2024 |
Identification of spatial specific lipid metabolic signatures in long-standing diabetic kidney disease
Yiran Zhang, Hai-long Piao, Di Chen |
Metabolites | 2024 |
Insulin Resistance, Obesity, and Lipotoxicity.
Yazıcı D, Demir SÇ, Sezer H |
Advances in experimental medicine and biology | 2024 |
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes
Ye Ji Choi, Gabriel Richard, Guanshi Zhang, Jeffrey B Hodgin, Dawit Demeke, Yingbao Yang, Jennifer A. Schaub, Ian M. Tamayo, Bhupendra K Gurung, Abhijit S Naik, Viji Nair, Carissa Birznieks, Alexis MacDonald, Phoom Narongkiatikhun, Susan Gross, Lynette Driscoll, Maureen Flynn, Kalie Tommerdahl, Kristen J Nadeau, Viral N Shah, Tim Vigers, Janet Snell-Bergeon, Jessica Kendrick, Daniel H. van Raalte, Lu-Ping Li, Pottumarthi Prasad, Patricia Ladd, Bennett B Chin, David Z.I. Cherney, Phillip J. McCown, Fadhl Alakwaa, Edgar A. Otto, Frank Brosius, Pierre Jean Saulnier, Victor G. Puelles, Jesse A. Goodrich, Kelly Street, Manjeri A. Venkatachalam, Aaron Ruiz, Ian H. de Boer, Robert G. Nelson, Laura Pyle, Denis Blondin, Kumar Sharma, Matthias Kretzler, Petter Bjornstad |
Journal of Clinical Investigation | 2024 |
Metabolic Chaos in Kidney Disease: Unraveling Energy Dysregulation
Gupta P, Zhu S, Gui Y, Zhou D |
Journal of Clinical Medicine | 2024 |
Unraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and Immunometabolism
Narongkiatikhun P, Choi YJ, Hampson H, Gotzamanis J, Zhang G, van Raalte DH, de Boer IH, Nelson RG, Tommerdahl KL, McCown PJ, Kanter J, Sharma K, Bjornstad P, Saulnier PJ |
Kidney International Reports | 2024 |
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Hill C, McKnight AJ, Smyth LJ |
Diabetic Medicine | 2024 |
Metabolomic and Lipidomic Profiling for Pre-Transplant Assessment of Delayed Graft Function Risk Using Chemical Biopsy with Microextraction Probes
Warmuzińska N, Łuczykowski K, Stryjak I, Wojtal E, Woderska-Jasińska A, Masztalerz M, Włodarczyk Z, Bojko B |
International Journal of Molecular Sciences | 2024 |
Crosstalk between glomeruli and tubules.
Fogo AB, Harris RC |
Nature reviews. Nephrology | 2024 |
Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
Chen Y, Torta F, Koh HWL, Benke PI, Gurung RL, Liu JJ, Ang K, Shao YM, Chan GC, Choo JC, Ching J, Kovalik JP, Kalhan T, Dorajoo R, Khor CC, Li Y, Tang WE, Seah DEJ, Sabanayagam C, Sobota RM, Venkataraman K, Coffman T, Wenk MR, Sim X, Lim SC, Tai ES |
Diabetologia | 2024 |
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth onset type 2 diabetes
Jennifer Schaub, Fadhl AlAkwaa, Phillip J. McCown, Abhijit Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar Otto, Dawit Demeke, John Hartman, Damian Fermin, Christopher O'Connor, Lalita Subramanian, Markus Bitzer, Roger Harned, Patricia Ladd, Meda Pavkov, Laura Pyle, Subramaniam Pennathur, Ken Inoki, Jeffrey Hodgin, Frank III, Robert Nelson, Matthias Kretzler, Petter Bjornstad |
Journal of Clinical Investigation | 2023 |
Molecular mechanisms of diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, Dhanunjay Mukhi, Poonam Dhillon and Katalin Susztak |
Journal of Clinical Investigation | 2023 |
Metabolic differences in diabetic kidney disease patients with and without moderately increased albuminuria
Stein Hallan, Marius A Øvrehus, Manjula Darshi, Daniel Montemayor, Knut A Langlo, Per Bruheim, Kumar Sharma |
Kidney360 | 2023 |
Unilateral Nephrectomized SHR/NDmcr-cp Rat Shows a Progressive Decline of Glomerular Filtration With Tubular Interstitial Lesions
SHINOZAKI Y, FUKUI K, MAEKAWA M, TOYODA K, YOSHIUCHI H, INAGAKI K, UNO K, MIYAJIMA K, OHTA T |
2023 | |
The role of exercise in improving hyperlipidemia-renal injuries induced by a high-fat diet: a literature review
Chen JS, Xie PF, Feng H |
PeerJ | 2023 |
The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus
Li X, Miao Y, Fang Z, Zhang Q |
Diabetology & metabolic syndrome | 2023 |
The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease
Li L, Long J, Mise K, Poungavrin N, Lorenzi PL, Mahmud I, Tan L, Saha PK, Kanwar YS, Chang BH, Danesh FR |
The Journal of biological chemistry | 2023 |
Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes
Trischitta V, Mastroianno M, Scarale MG, Prehn C, Salvemini L, Fontana A, Adamski J, Schena FP, Cosmo SD, Copetti M, Menzaghi C |
BMJ Open Diabetes Research & Care | 2023 |
Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications
Hammad SM, Lopes-Virella MF |
International journal of molecular sciences | 2023 |
Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease
Dai ZC, Chen JX, Zou R, Liang XB, Tang JX, Yao CW |
Frontiers in immunology | 2023 |
Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization
Onodera T, Wang MY, Rutkowski JM, Deja S, Chen S, Balzer MS, Kim DS, Sun X, An YA, Field BC, Lee C, Matsuo EI, Mizerska M, Sanjana I, Fujiwara N, Kusminski CM, Gordillo R, Gautron L, Marciano DK, Hu MC, Burgess SC, Susztak K, Moe OW, Scherer PE |
Nature Communications | 2023 |
Plasma Citrate Levels Are Associated with an Increased Risk of Cardiovascular Mortality in Patients with Type 2 Diabetes (Zodiac-64)
Bourgonje AR, Connelly MA, van Goor H, van Dijk PR, Dullaart RP |
Journal of Clinical Medicine | 2023 |
Higher circulating levels of non-esterified fatty acids are associated with faster kidney function decline in post-menopausal women with type 2 diabetes: a pilot prospective study.
Mantovani A, Csermely A, Cappelli D, Taverna A, Sani E, Shtembari E, Pagani M, Targher G |
Acta Diabetologica | 2023 |
Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia
Chae SY, Kim Y, Park CW |
Antioxidants | 2023 |
Luteolin alleviates depression‐like behavior by modulating glycerophospholipid metabolism in the hippocampus and prefrontal cortex of LOD rats
Wu X, Xu H, Zeng N, Li H, Yao G, Liu K, Yan C, Wu L |
CNS Neuroscience & Therapeutics | 2023 |
Metabolite Profiling of CKD Progression in the Chronic Renal Insufficiency Cohort (CRIC) Study
Donghai Wen, Zihe Zheng, Aditya Surapaneni, Bing Yu, Linda Zhou, Wen Zhou, Dawei Xie, Haochang Shou, Julian Pacheco, Sahir Kalim, Jiang He, Chi-yuan Hsu, Afshin Parsa, Panduranga Rao, James Sondheimer, Raymond Townsend, Sushrut Waikar, Casey Rebholz, Michelle Denburg, Paul Kimmel, Ramachandran Vasan, Clary Clish, Josef Coresh, Harold Feldman, Morgan Grams, Eugene Rhee |
JCI Insight | 2022 |
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
X Mu, M Yang, P Ling, A Wu, H Zhou, J Jiang |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2022 |
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease
W Martin, Y Chuah, M Abdelaal, A Pedersen, D Malmodin, S Abrahamsson, M Hutter, C Godson, E Brennan, L Fändriks, C le Roux, N Docherty |
Frontiers in Endocrinology | 2022 |
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study
Zhang J, Fuhrer T, Ye H, Kwan B, Montemayor D, Tumova J, Darshi M, Afshinnia F, Scialla JJ, Anderson A, Porter AC, Taliercio JJ, Rincon-Choles H, Rao P, Xie D, Feldman H, Sauer U, Sharma K, Natarajan L |
American Journal of Nephrology | 2022 |
Development and Validation of a Model That Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
Yang J, Jiang S |
International journal of general medicine | 2022 |
A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy
Rumora AE, Guo K, Hinder LM, O\u2019Brien PD, Hayes JM, Hur J, Feldman EL |
Frontiers in physiology | 2022 |
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
Afshinnia F, Reynolds EL, Rajendiran TM, Soni T, Byun J, Savelieff MG, Looker HC, Nelson RG, Michailidis G, Callaghan BC, Pennathur S, Feldman EL |
Annals of Clinical and Translational Neurology | 2022 |
The Michigan O'Brien Kidney Research Center: transforming translational kidney research through systems biology.
Bitzer M, Ju W, Subramanian L, Troost JP, Tychewicz J, Steck B, Wiggins RC, Gipson DS, Gadegbeku CA, Brosius FC 3rd, Kretzler M, Pennathur S |
American journal of physiology. Renal physiology | 2022 |
Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells.
Kayampilly P, Roeser N, Rajendiran TM, Pennathur S, Afshinnia F |
Metabolites | 2022 |
Lipid droplet - mitochondria coupling: A novel lipid metabolism regulatory hub in diabetic nephropathy
Yang M, Luo S, Yang J, Chen W, He L, Liu D, Zhao L, Wang X |
Frontiers in Endocrinology | 2022 |
Integrated analysis of comprehensive metabolomics and network pharmacology to reveal the mechanisms of abelmoschus manihot (L.) medik. in the treatment of cisplatin-induced chronic kidney disease
Liao JC, Li CY, Teng FM, Jian-Chen, Yu JY, Ju WZ, Zou JD |
Frontiers in pharmacology | 2022 |
Present and future directions in diabetic kidney disease
Limonte CP, Kretzler M, Pennathur S, Pop-Busui R, de Boer IH |
Journal of Diabetes and its Complications | 2022 |
Lipidomic profiling in the Strong Heart Study identified American Indians at risk of chronic kidney disease
Zeng W, Beyene HB, Kuokkanen M, Miao G, Magliano DJ, Umans JG, Franceschini N, Cole SA, Michailidis G, Lee ET, Howard BV, Fiehn O, Curran JE, Blangero J, Meikle PJ, Zhao J |
Kidney International | 2022 |
Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy
Patrice E. Fort, Thekkelnaycke Rajendiran, Tanu Soni, Jaeman Byun, Yang Shan, Helen Looker, Robert G Nelson, Matthias Kretzler, George Michailidis, Jerome E Roger, Thomas Gardner, Steven F. Abcouwer, Subramaniam Pennathur, Farsad Afshinnia |
JCI Insight | 2021 |
Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease
KM Sas, J Lin, CH Wang, H Zhang, J Saha, TM Rajendiran, T Soni, V Nair, F Eichinger, M Kretzler, FC Brosius, G Michailidis, S Pennathur |
Metabolomics | 2021 |
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
AP Jiménez-Uribe, EY Hernández-Cruz, KJ Ramírez-Magaña, J Pedraza-Chaverri |
Biomolecules | 2021 |
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
J Baek, C He, F Afshinnia, G Michailidis, S Pennathur |
Nature Reviews Nephrology | 2021 |
Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes
AE Rumora, K Guo, FM Alakwaa, ST Andersen, EL Reynolds, ME Jørgensen, DR Witte, H Tankisi, M Charles, MG Savelieff, BC Callaghan, TS Jensen, EL Feldman |
Annals of Clinical and Translational Neurology | 2021 |
New insights into renal lipid dysmetabolism in diabetic kidney disease
A Mitrofanova, G Burke, S Merscher, A Fornoni |
World journal of diabetes | 2021 |
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
H Noels, M Lehrke, R Vanholder, J Jankowski |
Nature Reviews Nephrology | 2021 |
Lipid Disorders in NAFLD and Chronic Kidney Disease
M Yang, CA Geng, X Liu, M Guan |
Biomedicines | 2021 |
Urinary 2-Hydroxyglutarate Enantiomers Are Markedly Elevated in a Murine Model of Type 2 Diabetic Kidney Disease
J Baek, S Pennathur |
Metabolites | 2021 |
In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
B Linnan, W Yanzhe, Z Ling, L Yuyuan, C Sijia, X Xinmiao, L Fengqin, W Xiaoxia |
Frontiers in physiology | 2021 |
Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes
F Afshinnia, T Rajendiran, C He, J Byun, D Montemayor, M Darshi, J Tumova, J Kim, C Limonte, R Miller, T Costacou, T Orchard, T Ahluwalia, P Rossing, J Snell-Bergeon, I de Boer, L Natarajan, G Michailidis, K Sharma, S Pennathur |
Diabetes care | 2021 |
Perspectives in systems nephrology
MT Lindenmeyer, F Alakwaa, M Rose, M Kretzler |
Cell and Tissue Research | 2021 |
Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease
WW Pan, TW Gardner, JL Harder |
Journal of Clinical Medicine | 2021 |
TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
A Santiago-Hernandez, M Martin-Lorenzo, A Martin-Blazquez, G Ruiz-Hurtado, MG Barderas, J Segura, LM Ruilope, G Alvarez-Llamas |
Antioxidants | 2021 |
Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications
X Li, Y Li, Y Liang, R Hu, W Xu, Y Liu |
Diabetes & Metabolism Journal | 2021 |
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Q Jin, RC Ma |
Cells | 2021 |
Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury
WP Martin, YH Chuah, E Conroy, AL Reynolds, C Judge, FJ López-Hernández, CW le Roux, NG Docherty |
2021 | |
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
L Opazo-Ríos, S Mas, G Marín-Royo, S Mezzano, C Gómez-Guerrero, JA Moreno, J Egido |
International journal of molecular sciences | 2020 |
A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes
CP Limonte, E Valo, D Montemayor, F Afshinnia, TS Ahluwalia, T Costacou, M Darshi, C Forsblom, AN Hoofnagle, PH Groop, RG Miller, TJ Orchard, S Pennathur, P Rossing, N Sandholm, JK Snell-Bergeon, H Ye, J Zhang, L Natarajan, IH de Boer, K Sharma |
American Journal of Nephrology | 2020 |
Strategies to educe severe diabetic foot nfections and complications uring pidemics (STRIDE)
BM Schmidt, ME Munson, GM Rothenberg, CM Holmes, R Pop-Busui |
Journal of Diabetes and its Complications | 2020 |
Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease
S Liu, C Wang, H Yang, T Zhu, H Jiang, J Chen |
Annals of translational medicine | 2020 |
The emerging role of dyslipidemia in diabetic microvascular complications.
Savelieff MG, Callaghan BC, Feldman EL |
Current opinion in endocrinology, diabetes, and obesity | 2020 |
Lipids and Cardiovascular Risk with CKD
F Afshinnia, S Pennathur |
Clinical journal of the American Society of Nephrology : CJASN | 2019 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |